Page last updated: 2024-08-25

tocophersolan and Acute Liver Injury, Drug-Induced

tocophersolan has been researched along with Acute Liver Injury, Drug-Induced in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Lin, X; Wang, H; Wu, Y1
Adu-Frimpong, M; Deng, W; Li, W; Li, Y; Ma, P; Sun, C; Xu, X; Yu, J; Zhang, H; Zhu, Y1

Other Studies

2 other study(ies) available for tocophersolan and Acute Liver Injury, Drug-Induced

ArticleYear
Crizotinib loaded polydopamine-polylactide-TPGS nanoparticles in targeted therapy for non-small cell lung cancer.
    Medical oncology (Northwood, London, England), 2022, Dec-02, Volume: 40, Issue:1

    Topics: Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Crizotinib; Humans; Lung Neoplasms; Nanoparticles

2022
Development of TPGS/F127/F68 mixed polymeric micelles: Enhanced oral bioavailability and hepatoprotection of syringic acid against carbon tetrachloride-induced hepatotoxicity.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2020, Volume: 137

    Topics: Administration, Oral; Animals; Biological Availability; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Drug Carriers; Drug Delivery Systems; Gallic Acid; Humans; Liver; Male; Mice; Mice, Inbred ICR; Micelles; Nanoparticles; Oxidative Stress; Polyethylene Glycols; Polyethylenes; Polypropylenes; Propylene Glycols; Rats; Rats, Sprague-Dawley; Vitamin E

2020